Is Allogene Therapeutics, Inc. (ALLO) a Buy, Sell, or Hold?
Allogene Therapeutics, Inc.
NASDAQ:ALLO
$1.85 USD
-$0.08 (-4.15%)
- Volume
- 5.42M
- Average Volume
- 11.78M
- Market Capitalization
- $451.16M
- P/E Ratio
- -2.40
- Dividend Yield
- 0.00%
- Price Target
- $6.43
- Year High
- $4.46
- Year Low
- $0.98
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.65
Analyst Rating
Strong Sell
1 Rating Score
UPSIDE/DOWNSIDE
-71.2% DOWNSIDE
$6.43 Price Target
UPSIDE/DOWNSIDE HIGH
-79.4% DOWNSIDE
$9.00 Price Target High
UPSIDE/DOWNSIDE LOW
-51.9% DOWNSIDE
$3.85 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Debjit Chattopadhyay | $9 | $2.98 | 2024-05-16 02:44 AM | 202.0% |
| B.Riley Financial | Kalpit Patel | $7 | $2.9 | 2024-05-14 03:33 AM | 141.4% |
| Robert W. Baird | Jack Allen | $11 | $9.74 | 2022-06-13 07:19 PM | 12.9% |
| Guggenheim | Michael Schmidt | $35 | $15.29 | 2022-01-02 07:00 PM | 128.9% |
| Canaccord Genuity | John Newman | $55 | $17.62 | 2021-12-02 07:00 PM | 212.1% |
| Roth Capital | Anthony Butler | $35 | $13.13 | 2021-10-07 08:00 PM | 166.6% |
| Bank of America Securities | Jason Gerberry | $32 | $13.13 | 2021-10-07 08:00 PM | 143.7% |
| Oppenheimer | Mark Breidenbach | $40 | $13.13 | 2021-10-07 08:00 PM | 204.6% |